HIV Clinical Trial
Official title:
Connecting Resources for Urban Sexual Health
The overall goal of the CRUSH project is to enhance and extend a response to the local
HIV/AIDS epidemic in Alameda County with a set of innovative, evidence-based interventions
across the continuum of HIV prevention and care, targeting individuals and communities most
vulnerable to HIV. The East Bay AIDS Center, in partnership with the University of California
San Francisco's Center for AIDS Prevention Studies, the Gladstone Institutes, and several key
community-based organizations, are engaging in a participatory partnership to enhance and
implement HIV services which target the East Bay's highest risk population- young men who
have sex with men (Y/MSM). Specifically, the CRUSH Project is designed to evaluate a
combination of program approaches to address the sexual health care needs of young gay men of
color and their sexual partners by enhancing the current program activities of the Downtown
Youth Clinic (DYC).
We hypothesize that we can reduce the impact of HIV among Y/MSM by expanding the current DYC
services structure in two ways. We intend to expand HIV testing, and linkage to and retention
in care for youth who test HIV positive, providing them with intensive risk-reduction
counseling and antiretroviral treatment, and thereby ultimately reducing the risk of further
HIV transmission. And we intend for the first time to offer a comprehensive combination
package of preventive services to HIV-negative youth, including routine accesses to HIV/STI
screening and treatment, and access to HIV pre-exposure prophylaxis (PrEP).
The CRUSH Project will also have a substudy that will enroll HIV-negative participants who
are eligible to receive PEP. The substudy will evaluate the tolerability and acceptability of
a 28 day course of Stribild® given as post-exposure prophylaxis (PEP) to prevent sexual
acquisition of HIV-1 in Y/MSM of color.
The CRUSH Project (Connecting Resources for Urban Sexual Health) is a demonstration project
at Alta Bates Summit Medical Center's East Bay AIDS Center (EBAC) and Downtown Youth Clinic
(DYC) offering interventions aimed at reducing HIV-1 incidence among young MSM of color in
the East Bay region. CRUSH has two major components:
1. Providing enhanced testing and linkage to care (TLC+) for HIV positives, aimed at
increasing the proportion of HIV positive Y/MSM who are in care, virologically
suppressed, and receiving intensive risk reduction counseling.
2. Providing comprehensive sexual health services to high risk HIV-negatives, including but
not limited to the provision of PrEP and PEP when clinically appropriate.
In addition, the CRUSH Project will offer a substudy of CRUSH, and will enroll HIV negative
CRUSH participants who are eligible to receive PEP. Stribild® is a single-tablet, four-drug,
once-daily complete regimen that is FDA-approved for the treatment of HIV-1 infection in
treatment-naïve HIV-infected adults with estimated glomerular filtration rate
≥70ml/min/1.73m2. Because of limited data, no antiretroviral drug or combination of drugs has
been approved for PEP. Current PEP guidelines generally call for using a 28-day course of a
3-drug regimen that has been approved for the treatment of HIV-1 infection
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |